Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
-79.72%
-84.21%
-533.6%
123.07%
55.17%
35.55%
ROA
-59.6%
-47.05%
-47.06%
-47.06%
-47.06%
-47.06%
Total Assets
SEK 352,638.00K
SEK 352,638.00K
SEK 352,638.00K
SEK 352,638.00K
SEK 352,638.00K
SEK 352,638.00K
Sector average
SEK 2,857,190.78K
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
Net Income
-SEK 169,777.00K
-SEK 165,921.27K
-SEK 165,952.68K
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Diamyd Medical AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
-SEK 165,968.99K
-SEK 165,968.27K
-SEK 165,967.11K
Sector average
-SEK 2,851.32K
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
Valuation
SEK 1,751,324.85K
SEK 1,711,551.32K
SEK 1,711,875.34K
SEK 1,712,043.58K
SEK 1,712,036.15K
SEK 1,712,024.16K
Sector average
SEK 3,960,502.41K
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
Stock Price
SEK 11.30
SEK 11.04
SEK 11.05
SEK 11.05
SEK 11.05
SEK 11.05
Sector average
SEK 57.22
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
Diamyd Medical AB (publ) (DMYD-B.ST) Financial Forecast | Equlion
